文献速递瓣膜病与结构性心脏病

低危患者主动脉生物瓣置换后瓣叶增厚的CT影像研究

Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study.
PubMed 文献 · J Am Coll Cardiol · 2020-03-28

Evolut Low Risk试验子研究纳入未口服抗凝药的低危患者,在TAVR或外科主动脉瓣置换后30天和1年行CT成像,发现瓣叶低衰减增厚(HALT)和瓣叶运动减低(RLM)常见但动态变化,且与瓣膜血流动力学无关。

要点

  • TAVR与外科瓣置换后HALT和RLM发生率相近,1年时HALT约30%。
  • HALT或RLM的存在及严重程度不影响主动脉瓣血流动力学。
  • 低危患者生物瓣置换后CT异常发现常见但动态,无需常规抗凝。

核心结论

  • 低危患者自膨胀式TAVR或外科主动脉瓣置换后1年内CT显示的瓣叶增厚和运动减低常见但动态变化,且不伴血流动力学异常。

研究设计与样本

  • Evolut Low Risk随机试验的前瞻性子集,未口服抗凝药患者接受TAVR或外科主动脉瓣置换,术后30天和1年行CT成像,由独立核心实验室分析。

主要发现

  • 30天HALT频率:TAVR 31/179(17.3%),外科23/139(16.5%);RLM频率:TAVR 23/157(14.6%),外科19/133(14.3%)。
  • 1年HALT频率:TAVR 47/152(30.9%),外科33/116(28.4%);RLM频率:TAVR 45/145(31.0%),外科30/111(27.0%)。
  • 两个时间点主动脉瓣血流动力学状态均不受HALT或RLM存在或严重程度影响。
  • 瓣上自膨胀式TAVR与外科生物瓣植入后HALT和RLM发生率相似。

关键数值与推荐

  • HALT定义为CT上瓣叶低衰减增厚,RLM定义为瓣叶运动减低,采用标准化定义由核心实验室判定。

临床怎么用

  • 低危患者TAVR或外科生物瓣置换后CT发现HALT/RLM常见且多动态变化,不伴血流动力学异常时可能无需额外干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Subclinical leaflet thrombosis has been reported after bioprosthetic aortic valve replacement, characterized using 4-dimensional computed tomographic imaging by hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RLM). The incidence and clinical implications of these findings remain unclear. OBJECTIVES: The aim of this study was to determine the frequency, predictors, and hemodynamic and clinical correlates of HALT and RLM after aortic bioprosthetic replacement. METHODS: A prospective subset of patients not on oral anticoagulation enrolled in the Evolut Low Risk randomized trial underwent computed tomographic imaging 30 days and 1 year after transcatheter aortic valve replacement (TAVR) or surgery. The primary endpoint was the frequency of HALT at 30 days and 1 year, analyzed by an independent core laboratory using standardized definitions. Secondary endpoints included RLM, mean aortic gradient, and clinical events at 30 days and 1 year. RESULTS: At 30 days, the frequency of HALT was 31 of 179 (17.3%) for TAVR and 23 of 139 (16.5%) for surgery; the frequency of RLM was 23 of 157 (14.6%) for TAVR and 19 of 133 (14.3%) for surgery. At 1 year, the frequency of HALT was 47 of 152 (30.9%) for TAVR and 33 of 116 (28.4%) for surgery; the frequency of RLM was 45 of 145 (31.0%) for TAVR and 30 of 111 (27.0%) for surgery. Aortic valve hemodynamic status was not influenced by the presence or severity of HALT or RLM at either time point. The rates of HALT and RLM were similar after the implantation of supra-annular, self-expanding transcatheter, or surgical bioprostheses. CONCLUSIONS: The presence of computed tomographic imaging abnormalities of aortic bioprostheses were frequent but dynamic in the first year after self-expanding transcatheter and surgical aortic valve replacement, but these findings did not correlate with aortic valve hemodynamic status after aortic valve replacement in patients at low risk for surgery. (Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients; NCT02701283).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Blanke P, Leipsic JA, Popma JJ, et al. Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study. J Am Coll Cardiol. 2020. PMID: 32234463. doi:10.1016/j.jacc.2020.03.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。